AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis-Reference-Cited by-同舟云学术

AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis

Published:2023-08 Issue: Volume:381 Page:110566
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Syamprasad N.P.,Jain Siddhi,Rajdev Bishal,Panda Samir Ranjan,Gangasani Jagadeesh Kumar,Challa Veerabhadra Swamy,Vaidya Jayathirtha Rao,Kundu Gopal C.,Naidu V.G.M.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference36 articles.

1. Doxorubicin, XPharm compr;Johnson-Arbor;Pharmacol. Ref.,2021

2. Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management;Rawat;Biomed. Pharmacother.,2021

3. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model;Christowitz;BMC Cancer,2019

4. Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells;Gavelová;Chem. Biol. Interact.,2008

5. Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization;Heibein;BMC Cancer,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma;JHEP Reports;2024-02

2. Drug screening identifies aldose reductase as a novel target for treating cisplatin-induced hearing loss;Free Radical Biology and Medicine;2024-01

3. Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity;Frontiers in Pharmacology;2023-12-08

4. Aldo-keto reductase 1B: Much learned, much more to do;hLife;2023-12

5. Echinacoside ameliorates doxorubicin‑induced cardiac injury by regulating GPX4 inhibition‑induced ferroptosis;Experimental and Therapeutic Medicine;2023-11-23